IV-361

Modify Date: 2024-07-09 23:54:49

IV-361 Structure
IV-361 structure
Common Name IV-361
CAS Number 2055741-39-2 Molecular Weight 457.62
Density N/A Boiling Point N/A
Molecular Formula C23H32FN5O2Si Melting Point N/A
MSDS N/A Flash Point N/A

 Use of IV-361


IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].

 Names

Name IV-361

 IV-361 Biological Activity

Description IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].
Related Catalog
Target

CDK7:≤50 nM (Ki)

CDK2:≥1000 nM (Ki)

In Vitro IV-361 has less inhibition on CDK2 (Ki≥1000 nM) or PLK1 (Ki≥5000 nM)[1]. IV-361 exhibits excellent IL-2 and IL-17 production inhibitory activity (all IC50≤100 nM) in periphery blood mononuclear cell (PBMC)[1]. IV-361 exhibits excellent HCT-116 cell growth inhibitory activity (GI50≤100 nM)[1].
In Vivo IV-361 (25 mg/kg/day; orally) exhibits 46% or more rate of suppression of tumor volume in female BALB nude mice with HCT-116[1].
References

[1]. Noriaki Iwase, et al. Substituted dihydropyrrolopyrazole derivative. US20190256531A1.

 Chemical & Physical Properties

Molecular Formula C23H32FN5O2Si
Molecular Weight 457.62